Gland Pharma IPO Details
IPO Date	November 9, 2020 to November 11, 2020
Listing Date	November 20, 2020
Face Value	₹1 per share
Issue Price Band	₹1490 to ₹1500 per share
Issue Price Final	₹1500 per share
Lot Size	10 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	4,31,96,968 shares
(aggregating up to ₹6,479.55 Cr)
Fresh Issue	83,33,333 shares
(aggregating up to ₹1,250.00 Cr)
Offer for Sale	3,48,63,635 shares of ₹1
(aggregating up to ₹5,229.55 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	15,49,49,490 shares
Share Holding Post Issue	16,32,82,823 shares
Gland Pharma IPO Reservation
Gland Pharma IPO offers total 4,31,96,968 shares. Out of which 2,15,98,483 (50.00%) allocated to QIB, 86,39,394 (20.00%) allocated to QIB, 64,79,546 (15.00%) allocated to NII, 1,51,18,939 (35.00%) allocated to RII and 1,29,59,089 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	2,15,98,483 (50.00%)	NA
NII (HNI) Shares Offered	64,79,546 (15.00%)	NA
Retail Shares Offered	1,51,18,939 (35.00%)	15,11,893
Total Shares Offered	4,31,96,968 (100.00%)	
Gland Pharma IPO Anchor Investors Details
Gland Pharma IPO raises ₹1,943.86 crore from anchor investors. Gland Pharma IPO Anchor bid date is November 6, 2020. Gland Pharma IPO Anchor Investors list

Bid Date	November 6, 2020
Shares Offered	1,29,59,089
Anchor Portion Size (In Cr.)	1,943.86
Anchor lock-in period end date for 50% shares (30 Days)	December 17, 2020
Anchor lock-in period end date for remaining shares (90 Days)	February 15, 2021
Gland Pharma IPO Timeline (Tentative Schedule)
Gland Pharma IPO opens on November 9, 2020, and closes on November 11, 2020.

IPO Open Date	Mon, Nov 9, 2020
IPO Close Date	Wed, Nov 11, 2020
Tentative Allotment	Tue, Nov 17, 2020
Initiation of Refunds	Wed, Nov 18, 2020
Credit of Shares to Demat	Thu, Nov 19, 2020
Tentative Listing Date	Fri, Nov 20, 2020
Cut-off time for UPI mandate confirmation	5 PM on Wed, Nov 11, 2020
Gland Pharma IPO Lot Size
Investors can bid for a minimum of 10 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	10	₹15,000
Retail (Max)	13	130	₹1,95,000
S-HNI (Min)	14	140	₹2,10,000
S-HNI (Max)	66	660	₹9,90,000
B-HNI (Min)	67	670	₹10,05,000
Gland Pharma IPO Promoter Holding
Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd is the company promoters.
Promoter Holding Pre Issue	74%
Promoter Holding Post Issue	58%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Gland Pharma Ltd.
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.

The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers.

It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs.

Company Strengths

The extensive product portfolio of complex injectables.
Diversified B2B model with a targeted B2C model in India.
Strong manufacturing capabilities.
Robust financial track record.
Experienced and qualified managerial team.
Company Financials
Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (Rs in million)
30-June-20	31-Mar-20	31-Mar-19	31-Mar-18
Total Assets	46,912.65	40,860.39	35,235.49	29,294.68
Total Revenue	9,162.89	27,724.08	21,297.67	16,716.82
Profit After Tax	3,135.90	7,728.58	4,518.56	3,210.51
Objects of the Issue (Gland Pharma IPO Objectives)
The Company Gland Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No.	Objects of the Issue	Expected Amount (₹ in crores)
1	Funding incremental working capital requirements of our Company	769.50
2	Funding capital expenditure requirements of our Company	168.00
3	General corporate purposes	286.47
Gland Pharma IPO Review
[Dilip Davda]  No doubt that currently, the pharma sector is attracting investors following COVID-19 pandemic and the search of remedies for it globally. This company has posted good performance for the last three fiscals and spectacular numbers for Q1 of FY21, but will it sustain going forward is a major concern in the present context of negative sentiment for China connections globally. Based on P/BV and P/E parameters, the issue appears fully priced. Considering all these, though it sounds lucrative bet for the long term, risk savvy, cash surplus investors may consider investment at their own risk in this China connected IPO. Read detail review...

Gland Pharma IPO Subscription Status (Bidding Detail)
The Gland Pharma IPO is subscribed 2.06 times on November 11, 2020 6:00:01 PM (Day 3). The public issue subscribed 0.24 times in the retail category, 6.4 times in the QIB category, and 0.51 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	6.4	86,39,394	5,52,50,350
NII	0.51	64,79,546	32,94,470
Retail	0.24	1,51,18,939	36,10,850
Total	2.06	3,02,37,879	6,21,55,670
Related Articles

Gland Pharma IPO - Subscribe Says Research Analysts
Gland Pharma IPO opens on 9th November 2020
Gland Pharma IPO Prospectus
  ›  Gland Pharma IPO DRHP
  ›  Gland Pharma IPO RHP
  ›  Anchor Investors in Gland Pharma IPO
  ›  Gland Pharma IPO Final Prospectus
Gland Pharma IPO Listing Details
Listing Date	November 20, 2020
BSE Script Code	543245
NSE Symbol	GLAND
ISIN	INE068V01023
Final Issue Price	₹1500 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹1,500.00	₹1,500.00
Open	₹1,701.00	₹1,710.00
Low	₹1,701.00	₹1,700.00
High	₹1,850.00	₹1,850.00
Last Trade	₹1,820.45	₹1,819.55